Estimating subject-specific survival functions under the accelerated failure time model
From MaRDI portal
Recommendations
- scientific article; zbMATH DE number 70009
- Predicting Survival Probabilities With Semiparametric Transformation Models
- Efficient Estimation for the Accelerated Failure Time Model
- Modelling accelerated failure time with a Dirichlet process
- Confidence Intervals for the Survival Function Using Cox's Proportional- Hazard Model with Covariates
Cited in
(24)- Testing error heterogeneity in censored linear regression
- Landmark estimation of survival and treatment effects in observational studies
- Tests of independence for censored bivariate failure time data
- On the restricted mean survival time curve in survival analysis
- Evaluating prognostic accuracy of biomarkers under competing risk
- Evaluating marker-guided treatment selection strategies
- Kernel Machine Approach to Testing the Significance of Multiple Genetic Markers for Risk Prediction
- Semiparametric models of time-dependent predictive values of prognostic biomarkers
- Estimation of Survival Functions and Failure Rate
- Landmark prediction of long-term survival incorporating short-term event time information
- Subgroup specific incremental value of new markers for risk prediction
- Incorporating diagnostic accuracy into the estimation of discrete survival function
- Incorporating short-term outcome information to predict long-term survival with discrete markers
- Resampling procedures for making inference under nested case-control studies
- Robust dynamic risk prediction with longitudinal studies
- Subgroup specific incremental value of new markers for risk prediction
- Discussion of “A Risk-Based Measure of Time-Varying Prognostic Discrimination for Survival Models,” by C. Jason Liang and Patrick J. Heagerty
- The effect of winning an Oscar Award on survival: correcting for healthy performer survivor bias with a rank preserving structural accelerated failure time model
- Inference for covariate-adjusted time-dependent prognostic accuracy measures
- Robust estimation of the proportion of treatment effect explained by surrogate marker information
- Landmark risk prediction of residual life for breast cancer survival
- Towards optimal use of surrogate markers to improve power
- Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study
- Profiling heteroscedasticity in linear regression models
This page was built for publication: Estimating subject-specific survival functions under the accelerated failure time model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2813885)